InMed Pharmaceuticals Inc.

INM | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.36

-$0.03 (-2.16%)

At close: Sep 18, 2026, 4:00 PM ET

$1.35

-$0.01 (-0.65%)

Pre-market: Sep 21, 2026, 8:41 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.16%

(1D)

Rating

Updated: Sep 12, 2026

49.5

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $2.46M

1D Range

1.36 1.42

52W Range

0.58 2.50

Valuation (TTM)

PE 0

PB 0.00

EV/EBITDA -4.76

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -286026.5%

SBC Adj. FCF Yield -293238.7%

SBC Impact -2.5%

Margins

Gross Margin 14.9%

Operating Margin 25.2%

FCF Margin -341.8%

Growth (CAGR)

Revenue 3Y | 5Y 635.6% | 99.2%

Dil EPS 3Y | 5Y -141.0% | -15.5%

FCF 3Y | 5Y -149.5% | -99.3%

Returns

ROA -414.5%

ROE -134.7%

ROIC -995.4%

Financial Health

Net Cash

$2.23B

Current Ratio 1.37

Interest Coverage -1,000.10

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 13

IPO Date May 4, 2014

Website www.inmedpharma.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Sep 23, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞